These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31388120)

  • 1. The changing spectrum of hypertension in premature infants.
    Farnbach K; Iragorri S; Al-Uzri A; Rozansky D; Forbush R; Jenkins R
    J Perinatol; 2019 Nov; 39(11):1528-1534. PubMed ID: 31388120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of hypertension in premature infants with and without chronic lung disease: a long-term multi-center study.
    Jenkins RD; Aziz JK; Gievers LL; Mooers HM; Fino N; Rozansky DJ
    Pediatr Nephrol; 2017 Nov; 32(11):2115-2124. PubMed ID: 28674750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma renin activity and aldosterone concentrations in hypertensive cats with and without azotemia and in response to treatment with amlodipine besylate.
    Jepson RE; Syme HM; Elliott J
    J Vet Intern Med; 2014; 28(1):144-53. PubMed ID: 24428319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phthalate-associated hypertension in premature infants: a prospective mechanistic cohort study.
    Jenkins R; Tackitt S; Gievers L; Iragorri S; Sage K; Cornwall T; O'Riordan D; Merchant J; Rozansky D
    Pediatr Nephrol; 2019 Aug; 34(8):1413-1424. PubMed ID: 31028470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of plasma renin concentration instead of plasma renin activity decreases the positive aldosterone-to-renin ratio tests in treated patients with essential hypertension.
    Lonati C; Bassani N; Gritti A; Biganzoli E; Morganti A
    J Hypertens; 2014 Mar; 32(3):627-34. PubMed ID: 24445391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Plasma Renin Activity After Renal Artery Sympathetic Denervation.
    Mahfoud F; Townsend RR; Kandzari DE; Kario K; Schmieder RE; Tsioufis K; Pocock S; David S; Patel K; Rao A; Walton A; Bloom JE; Weber T; Suppan M; Lauder L; Cohen SA; McKenna P; Fahy M; Böhm M; Weber MA
    J Am Coll Cardiol; 2021 Jun; 77(23):2909-2919. PubMed ID: 33957242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phthalates cause a low-renin phenotype commonly found in premature infants with idiopathic neonatal hypertension.
    Jenkins RD
    Pediatr Nephrol; 2023 Jun; 38(6):1717-1724. PubMed ID: 36322257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication.
    Seiler L; Rump LC; Schulte-Mönting J; Slawik M; Borm K; Pavenstädt H; Beuschlein F; Reincke M
    Eur J Endocrinol; 2004 Mar; 150(3):329-37. PubMed ID: 15012618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low plasma renin activity and high aldosterone/renin ratio are associated with untreated isolated systolic hypertension.
    Durukan M; Guray U; Aksu T; Guray Y; Demirkan B; Korkmaz S
    Blood Press; 2012 Oct; 21(5):320-5. PubMed ID: 22587638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
    Schwartz GL; Turner ST
    Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between plasma renin activity and birth weight in hypertensive pregnancy.
    Taufield PA; Druzin ML; Edersheim TE; Sealey JE; Laragh JH
    J Hypertens Suppl; 1986 Dec; 4(5):S96-8. PubMed ID: 3553491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs.
    Huang X; Li J; Liu L; Chen G; Yi Y; Li P; Wu Y; Xu Y; Bao H; Yu L; Qin X; Zhang Y; Wang B; Li J; Fan Hou F; Huo Y; Cheng X; Spence JD
    Hypertens Res; 2019 Dec; 42(12):1971-1978. PubMed ID: 31562418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone?
    Mahmud A; Mahgoub M; Hall M; Feely J
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone Levels, Aortic Stiffness, and Wave Reflection in Essential Hypertensive Patients.
    Tzamou V; Kyvelou SM; Karpanou E; Petras D; Vyssoulis G
    Am J Hypertens; 2015 Jul; 28(7):852-7. PubMed ID: 25542624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race, obesity, and the renin-angiotensin-aldosterone system: treatment response in children with primary hypertension.
    South AM; Arguelles L; Finer G; Langman CB
    Pediatr Nephrol; 2017 Sep; 32(9):1585-1594. PubMed ID: 28411317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of characteristics of renin, aldosterone and aldosterone/renin ratio in patients with aldosterone-producing adenoma].
    He YB; Yu X; Zhou XR; Shu BH; Liu JH
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3379-83. PubMed ID: 24418036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and renal effects of isradipine in essential hypertension: focus on renin system activity.
    Allikmets K; Parik T; Teesalu R
    Angiology; 1997 Nov; 48(11):977-83. PubMed ID: 9373050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pressor agents on blood pressure, plasma renin activity and plasma aldosterone concentration in essential hypertension.
    Yamamoto Y
    Jpn Heart J; 1975 Jul; 16(4):404-20. PubMed ID: 1152295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma renin and aldosterone measurements in low renin hypertensive states.
    Sealey JE; Gordon RD; Mantero F
    Trends Endocrinol Metab; 2005 Apr; 16(3):86-91. PubMed ID: 15808804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.